XML 49 R45.htm IDEA: XBRL DOCUMENT v3.3.0.814
Business Segment Information (Details)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 26, 2015
USD ($)
Sep. 27, 2014
USD ($)
Sep. 26, 2015
USD ($)
Segment
Sep. 27, 2014
USD ($)
Dec. 31, 2014
USD ($)
Business Segments          
Number of Reportable Segments | Segment     4    
Segment Reporting Information [Line Items]          
Revenues $ 4,123.2 $ 4,171.4 $ 12,312.9 $ 12,396.8  
Cost of revenues charges (0.8)   (2.5)    
Selling, general and administrative charges, net (24.6)   (35.4)    
Restructuring and other income (costs), net (15.5) 110.6 (67.9) 631.9  
Operating Income 562.9 640.3 1,646.0 1,863.9  
Other expense, net (94.8) (101.1) (292.3) (313.8)  
Income from Continuing Operations Before Income Taxes 468.1 539.2 1,353.7 1,550.1  
Depreciation 97.8 92.8 274.9 263.7  
Total Assets 41,147.1   41,147.1   $ 42,852.1
Capital Expenditures     293.5 270.9  
Life Sciences Solutions [Member]          
Segment Reporting Information [Line Items]          
Cost of revenues charges (0.4)   (1.8)    
Selling, general and administrative charges, net (2.7)   (8.9)    
Restructuring and other income (costs), net (5.0)   (31.1)    
Analytical Instruments [Member]          
Segment Reporting Information [Line Items]          
Cost of revenues charges (0.1)   (0.1)    
Selling, general and administrative charges, net 0.0   0.0    
Restructuring and other income (costs), net (4.1)   (22.5)    
Specialty Diagnostics [Member]          
Segment Reporting Information [Line Items]          
Cost of revenues charges (0.3)   (0.6)    
Selling, general and administrative charges, net 0.4   0.4    
Restructuring and other income (costs), net (1.6)   (6.3)    
Laboratory Products and Services [Member]          
Segment Reporting Information [Line Items]          
Cost of revenues charges 0.0   0.0    
Selling, general and administrative charges, net (0.8)   (1.6)    
Restructuring and other income (costs), net (4.8)   (7.7)    
Total Reportable Segments [Member]          
Segment Reporting Information [Line Items]          
Operating Income [1] 933.7 915.0 2,740.6 2,669.1  
Total Reportable Segments [Member] | Life Sciences Solutions [Member]          
Segment Reporting Information [Line Items]          
Revenues 1,080.4 1,071.9 3,229.6 3,010.5  
Operating Income [1] 332.7 306.3 954.9 850.0  
Depreciation 38.4 37.1 106.7 97.4  
Total Reportable Segments [Member] | Analytical Instruments [Member]          
Segment Reporting Information [Line Items]          
Revenues 778.5 786.5 2,282.9 2,349.8  
Operating Income [1] 146.5 137.8 407.8 399.1  
Depreciation 9.9 9.4 28.6 29.0  
Total Reportable Segments [Member] | Specialty Diagnostics [Member]          
Segment Reporting Information [Line Items]          
Revenues 776.9 811.8 2,379.2 2,480.6  
Operating Income [1] 204.9 224.3 646.2 681.7  
Depreciation 18.8 19.4 54.6 57.4  
Total Reportable Segments [Member] | Laboratory Products and Services [Member]          
Segment Reporting Information [Line Items]          
Revenues 1,638.2 1,628.7 4,844.9 4,918.6  
Operating Income [1] 249.6 246.6 731.7 738.3  
Depreciation 30.7 26.9 85.0 79.9  
Intersegment Eliminations [Member]          
Segment Reporting Information [Line Items]          
Revenues (150.8) (127.5) (423.7) (362.7)  
Segment Reconciling Items [Member]          
Segment Reporting Information [Line Items]          
Cost of revenues charges (0.8) (2.1) (2.5) (326.7)  
Selling, general and administrative charges, net (24.6) (20.3) (35.4) (118.0)  
Restructuring and other income (costs), net (15.5) 110.6 (67.9) 631.9  
Amortization of acquisition-related intangible assets $ (329.9) $ (362.9) $ (988.8) $ (992.4)  
[1] Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs, net; and amortization of acquisition-related intangibles.